High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?

被引：0
作者：
Stadtmauer, EA [1 ]
机构：
[1] Univ Penn, Ctr Canc, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 81卷
关键词：
high dose chemotherapy; metastatic breast cancer; stem cell transplant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are low and small differences may exist particularly in subsets of patients, the duration of follow-up is adequate to make the likelihood of a late benefit low. High dose chemotherapy with stem cell transplantation does not have a place in the treatment of metastatic breast cancer outside of clinical trials.
引用
收藏
页码：S111 / S115
页数：5
相关论文
共 50 条
  • [1] High Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Breast Cancer: Is there a Place?
    Edward A. Stadtmauer
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 111 - 115
  • [2] Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer
    Schneeweiss, A
    Hensel, M
    Goerner, R
    Khbeis, T
    Hohaus, S
    Egerer, G
    Solomayer, E
    Haas, R
    Grischke, EM
    Bastert, G
    Ho, AD
    STEM CELLS, 2001, 19 (02) : 151 - 160
  • [3] High-dose chemotherapy and autologous stem-cell transplantation in breast cancer
    Kier, P
    Ruckser, R
    Buxhofer, V
    Habertheuer, K
    Zelenka, P
    Tatzreiter, G
    Hübl, G
    Kittl, E
    Hauser, A
    Sebesta, C
    Hinterberger, W
    ACTA MEDICA AUSTRIACA, 2000, 27 : 33 - 36
  • [4] High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
    Y. Tokuda
    Masatoshi Ohta
    Akira Okumura
    Soichi Kuge
    Mitsuhiro Kubota
    Tomoo Tajima
    Toshio Mitomi
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S94 - S99
  • [5] High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer
    Tokuda, Y
    Ohta, M
    Okumura, A
    Kuge, S
    Kubota, M
    Tajima, T
    Mitomi, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 : S94 - S99
  • [6] High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Breast Cancer: Is There Still a Hope?
    Demirer, Taner
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (03): : 182 - 187
  • [7] Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation
    Boudin, Laurys
    Chabannon, Christian
    Sfumato, Patrick
    Sabatier, Renaud
    Bertucci, Francois
    Tarpin, Carole
    Provansal, Magali
    Houvenaegel, Gilles
    Lambaudie, Eric
    Tallet, Agnes
    Resbeut, Michel
    Charafe-Jauffret, Emmanuelle
    Calmels, Boris
    Lemarie, Claude
    Boher, Jean-Marie
    Extra, Jean-Marc
    Viens, Patrice
    Goncalves, Anthony
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : 118 - 126
  • [8] Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support
    Hensel, M
    Schneeweiss, A
    Sinn, HP
    Egerer, G
    Kornacker, M
    Solomayer, E
    Haas, R
    Bastert, G
    Ho, AD
    STEM CELLS, 2002, 20 (01) : 32 - 40
  • [9] High-dose chemotherapy with autologous stem cell rescue in breast cancer
    Dillman, RO
    Barth, NM
    Nayak, SK
    DeLeon, C
    OConnor, A
    Morrelli, L
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (03) : 277 - 289
  • [10] Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
    Sayer, HG
    Schilling, K
    Vogt, T
    Blumenstengel, K
    Issa, MC
    Mügge, LO
    Kasper, C
    Kath, R
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (06) : 361 - 366
12345